Industry Educational Session - Order Matters: Sequencing Strategies for Optimised Myeloma Care – Sponsored by Johnson & Johnson
Tracks
-
| Monday, April 28, 2025 |
| 2:20 PM - 3:05 PM |
| M1 |
Details
A symposium exploring treatment sequencing strategies in multiple myeloma. Expert panellists will discuss the importance of early anti-CD38 utilisation to secure patient eligibility for T-cell redirecting therapies. Patient profiles will be used to illustrate experts’ treatment decision-making across lines of therapy, with special focus on relapsed / refractory patients who are anti-CD38 naïve and exposed.
This promotional symposium is fully developed and funded by Johnson & Johnson for UK healthcare professionals. Johnson & Johnson products will be discussed, and prescribing information and adverse event reporting will be available at the meeting.
Job bag: CP-496698 | Date of Preparation: February 2025
Speaker
Dr. Jindriska Lindsay
Consultant
East Kent University Hospitals NHS FT
-
Dr. Sally Moore
Consultant
University Hospitals Bristol & Weston NHS FT
-
Dr. Neil Rabin
Consultant
University College London Hospitals
-
